Antibiotics needed to treat multidrug-resistant infections in neonates

Phoebe Cm Williams1, Shamim A Qazi2, Ramesh Agarwal3

  • 1School of Public Health, Faculty of Medicine, Edward Ford Building, The University of Sydney, Camperdown, NSW, 2006, Australia.

Insights

Neonatal infections are a major cause of death, with limited antibiotic options for drug-resistant strains. Developing a priority list for neonatal antibiotics is crucial to accelerate research and reduce infant mortality.

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Pharmacology

Background:

  • Neonatal infections are a primary cause of mortality globally.
  • Antimicrobial resistance (AMR) and a sparse antibiotic pipeline hinder effective neonatal treatment.
  • Few antibiotics approved for adults include neonatal dosing, highlighting a critical research gap.

Approach:

  • Review the World Health Organization (WHO) priority pathogens list for neonatal sepsis.
  • Propose a WHO multiexpert stakeholder meeting to establish a neonatal priority antibiotic development list.
  • Advocate for an international, interdisciplinary consensus to accelerate neonatal antibiotic development.

Key Points:

  • Only 4 of 40 antibiotics approved since 2000 include neonatal dosing.
  • Adult antibiotic trials significantly outnumber neonatal trials (43 vs. 6).
  • Addressing AMR in neonates requires a focused, accelerated development program.

Conclusions:

  • A dedicated neonatal antibiotic development program is essential.
  • Prioritizing specific antibiotics for neonates will streamline research efforts.
  • Reducing morbidity and mortality from multidrug-resistant infections in neonates is achievable through focused international collaboration.

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.4K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
422
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
29
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
90
Antibiotic Selection00:57

Antibiotic Selection

Overview
55.0K
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
23